Mikael Svensson
Chief Executive Officer
Mikael is a seasoned executive with over 25 years of experience leading consumer health, medical device, and pharmaceutical companies across North America and global markets.
He brings a diverse background in leading U.S. and international medical device and pharmaceutical companies, with a focus on medical aesthetics, dermatology, consumer health, and the beauty sector.
Trained as a chemical engineer, Mikael built his career on a foundation of international sales, strategic marketing, and commercial operations — successfully leading global expansions and product launches. He has overseen the scaling of dermatology and podiatry products such as Naftin, topical OTC brands including Mederma and VagiVital, and spearheaded the worldwide expansion of Restylane in aesthetics.
Mikael also led the launch of INOmax, an FDA-approved inhaled nitric oxide therapy for hypoxic respiratory failure in newborns, across the U.S. and Europe.
Today, as CEO of NoWonder, he is leading the company’s commercial growth by bringing nitric-oxide-powered innovations to consumers and physician practices worldwide.
Chris Miller, PhD, BA, RT
Chief Science Officer, SaNOtize Cofounder
A pioneer in nitric oxide technology and therapeutic research.
Dr. Chris Miller has over 30 years of experience in nitric oxide (NO) research, drug and device development, and commercialization. He has served as CEO and CSO for nitric oxide-focused biotech startups, leading fundraising, licensing, and clinical initiatives. His expertise spans clinical trial design, IP strategy, regulatory affairs, and scientific management.
John Sharp, CPA
Chief Financial Officer
Senior financial executive with over 20 years of experience in corporate finance, accounting, and strategy within the life sciences industry.
Over his career, John Sharp has led successful fundraising efforts for both private and public life sciences companies, raising nearly $400 million. He has also overseen multiple mergers and acquisitions totaling over $140 million.
Teri Meding
VP of Business Operations and Technology Innovation
Teri brings over two decades of experience leading business operations, technology initiatives, and enterprise change across large professional services organizations. She is known for translating complex challenges into practical solutions and guiding cross-functional teams through transformation.
At SaNOtize, she leads innovation and commercialization efforts with a focus on scalability, execution, and operational impact.
Jose Casillas
VP of Product Development and Manufacturing
With over 30 years of experience in the pharmaceutical and medical device industries, Jose has been instrumental in driving product development, product launches, and commercialization efforts.
Throughout his career, he has demonstrated deep expertise in engineering, strategic planning, and cross-functional leadership. Jose has successfully managed complex projects and fostered innovation to bring cutting-edge solutions to market.
Heather Morrow
Vice President, Medical Affairs
Dr. Heather Morrow is a seasoned Medical Affairs leader with deep expertise in aesthetics, dermatology, and visionary work in pharmaceutical and consumer integration. Her extensive background spans roles in biotech, eye health, and novel therapeutic platforms, where she bridges clinical science with strategic execution.